Kim; Je Hak

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kim; Je Hak.The latest application filed is for "pharmaceutical composition containing fimasartna and hydrochlorothiazide".

Company Profile

0.12.13

Kim; Je Hak - Anyang KR
Kim; Je Hak - Anyang-si KR
Kim; Je Hak - Gyeonggi-do N/A KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Fused ring heteroaryl compounds and their use as Trk inhibitors Grant 9,701,681 - Kim , et al. July 11, 2	2017-07-11
Pharmaceutical composition containing fimasartan and hydrochlorothiazide Grant 9,457,094 - Kim , et al. October 4, 2	2016-10-04
Compound having angiogenesis inhibitory activity, method for preparing same, and pharmaceutical composition comprising same Grant 9,227,955 - Kim , et al. January 5, 2	2016-01-05
Pharmaceutical Composition Containing Fimasartna And Hydrochlorothiazide App 20150147394 - Kim; Je Hak ; et al.	2015-05-28
Novel Compound Having Angiogenesis Inhibitory Activity, Method for Preparing Same, and Pharmaceutical Composition Comprising Same App 20140256711 - Kim; Ji Han ; et al.	2014-09-11
Antihypertensive pharmaceutical composition Grant 8,765,776 - Kim , et al. July 1, 2	2014-07-01
Combined Formulation With Improved Stability App 20140044784 - Kim; Je Hak ; et al.	2014-02-13
Antihypertensive Pharmaceutical Composition App 20120264772 - Kim; Seung Ho ; et al.	2012-10-18
Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor Grant 7,169,929 - Cho , et al. January 30, 2	2007-01-30
Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor Grant 7,135,572 - Cho , et al. November 14, 2	2006-11-14
Diary 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor App 20060009495 - Cho; II-hwan ; et al.	2006-01-12
Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor Grant 6,946,558 - Cho , et al. September 20, 2	2005-09-20
Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor App 20050075373 - Cho, Il-hwan ; et al.	2005-04-07
Bipyridinyl derivatives as a highl selective cyclooxygenase-2 inhibitor App 20040254378 - Cho, II-Hwan ; et al.	2004-12-16
3,4-dihydro-1H-naphthalene derivatives as a highly selective cyclooxygenase-2 inhibitor Grant 6,768,019 - Cho , et al. July 27, 2	2004-07-27
3,4-dihydro-1H-naphthalene derivatives as a highly selective cyclooxygenase-2 inhibitor Grant 6,686,493 - Cho , et al. February 3, 2	2004-02-03
3,4-Dihydro-1H-naphthalene derivatives as a highly selective cyclooxygenase-2 inhibitor App 20030187302 - Cho, Il Hwan ; et al.	2003-10-02
1H-indole derivatives as a highly selective cyclooxygenase-2 inhibitor Grant 6,599,929 - Cho , et al. July 29, 2	2003-07-29
1H-indole derivatives as a highly selective cyclooxygenase-2 inhibitor App 20030109568 - Cho, Il Hwan ; et al.	2003-06-12
3,4-Dihydro-1H-naphthalene derivatives as a highly selective cyclooxygenase-2 inhibitor App 20030109715 - Cho, Il Hwan ; et al.	2003-06-12
4'-Methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor App 20030105095 - Cho, Il Hwan ; et al.	2003-06-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.